Association between active pulmonary tuberculosis and miRNA-146a: A preliminary study from Serbia.

INTRODUCTION Tuberculosis (TB) continues to be a significant public health problem. The role of small non-coding RNAs, such as microRNAs (miRNAs), was investigated extensively in Mycobacterium tuberculosis (MTB) infection as well as in a variety of other pathophysiological processes in recent years. It was found that miRNAs act as regulators of both early reaction to MTB infection and in process of adaptation of the host immune cells during latent course of the disease. Molecule miRNA-146a is expressed exclusively in immune cells and it has the most prominent role in modulation of innate immunity. METHODOLOGY We investigated the level of expression of miRNA-146a using an RT-qPCR technique in peripheral blood mononuclear cells of 44 patients with active pulmonary TB and 17 healthy individuals. We also analyzed the significance of miRNA-146a rs2910164 SNV for expression profile of miRNA-146a, in order to investigate potential usage of miRNA-146a as a biomarker for TB. RESULTS There was statistically significant decrease of expression of miRNA-146a in TB group compared to control group. When gender cohorts were analyzed, the expression levels in TB male and TB female subgroup were significantly lower than the expression levels in the same gender control subgroups. CONCLUSIONS Our results indicate that miRNA-146a plays a significant role in the pathogenesis of TB, suggesting that miRNA-146a could be used as a biomarker for active pulmonary TB.

[1]  M. Uzun,et al.  Association between active pulmonary tuberculosis and circulating microRNAs: a preliminary study from Turkey , 2021, Turkish journal of medical sciences.

[2]  L. Barzon,et al.  Tuberculosis-Associated MicroRNAs: From Pathogenesis to Disease Biomarkers , 2020, Cells.

[3]  C. E. Condrat,et al.  miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis , 2020, Cells.

[4]  V. Spasovski,et al.  Relevance of TNF-α, IL-6 and IRAK1 gene expression for assessing disease severity and therapy effects in tuberculosis patients. , 2019, Journal of infection in developing countries.

[5]  Z. Salehi,et al.  Effects of miR-27a, miR-196a2 and miR-146a polymorphisms on the risk of breast cancer , 2018, British journal of biomedical science.

[6]  Kun Xu,et al.  Genetic polymorphisms of IL-17A, IL-17F, TLR4 and miR-146a in association with the risk of pulmonary tuberculosis , 2016, Scientific Reports.

[7]  G. Zeng,et al.  microRNA-146a promotes mycobacterial survival in macrophages through suppressing nitric oxide production , 2016, Scientific Reports.

[8]  J. Kanu,et al.  Association of Pre-miR-146a rs2910164 Polymorphism with Papillary Thyroid Cancer , 2015, International journal of endocrinology.

[9]  R. Chaisson,et al.  Latent Mycobacterium tuberculosis infection. , 2015, The New England journal of medicine.

[10]  Jicheng Li,et al.  Association of the miR-146a, miR-149, miR-196a2 and miR-499 polymorphisms with susceptibility to pulmonary tuberculosis in the Chinese Uygur, Kazak and Southern Han populations , 2015, BMC Infectious Diseases.

[11]  C. Franceschi,et al.  Circulating miR-21, miR-146a and Fas ligand respond to postmenopausal estrogen-based hormone replacement therapy – A study with monozygotic twin pairs , 2014, Mechanisms of Ageing and Development.

[12]  Wei Xu,et al.  MicroRNA-146a Represses Mycobacteria-Induced Inflammatory Response and Facilitates Bacterial Replication via Targeting IRAK-1 and TRAF-6 , 2013, PloS one.

[13]  H. Harapan,et al.  The roles of microRNAs on tuberculosis infection: meaning or myth? , 2013, Tuberculosis.

[14]  H. Jeon,et al.  A miR-146a polymorphism (rs2910164) predicts risk of and survival from colorectal cancer. , 2013, Anticancer research.

[15]  Thelma M. Escobar,et al.  STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis. , 2013, Investigative ophthalmology & visual science.

[16]  Arif A. Khan,et al.  MicroRNA-17~92 regulates effector and memory CD8 T-cell fates by modulating proliferation in response to infections. , 2013, Blood.

[17]  O. Bottasso,et al.  Altered microRNA expression levels in mononuclear cells of patients with pulmonary and pleural tuberculosis and their relation with components of the immune response. , 2013, Molecular immunology.

[18]  B. Ying,et al.  Genetic study of two single nucleotide polymorphisms within corresponding microRNAs and susceptibility to tuberculosis in a Chinese Tibetan and Han population. , 2011, Human immunology.

[19]  J. Rinn,et al.  Non-coding RNAs as regulators of embryogenesis , 2011, Nature Reviews Genetics.

[20]  S. Shenouda,et al.  MicroRNA function in cancer: oncogene or a tumor suppressor? , 2009, Cancer and Metastasis Reviews.

[21]  Pin Wang,et al.  MicroRNA-146a Feedback Inhibits RIG-I-Dependent Type I IFN Production in Macrophages by Targeting TRAF6, IRAK1, and IRAK21 , 2009, The Journal of Immunology.

[22]  M. Lindsay,et al.  microRNAs and the immune response. , 2008, Trends in immunology.

[23]  O. Crasta,et al.  Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. , 2008, Blood.

[24]  Barbara Jarzab,et al.  Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma , 2008, Proceedings of the National Academy of Sciences.

[25]  J. Mendell,et al.  MicroRNAs in cell proliferation, cell death, and tumorigenesis , 2006, British Journal of Cancer.